Sick-visit immunizations
Do sick-visit immunizations dampen parental incentive to return for missed well-baby examinations?
Do sick-visit immunizations dampen parental incentive to return for missed well-baby examinations? Apparently not, according to an examination of subsequent immunization levels and routine well-baby visits when sick visits for acute otitis media took the place of routine well-baby visits at 2, 4, or 6 months of age among a health plan population. No differences were detected in immunization rates or well-baby visits through 24 months of age between infants who received sick-visit immunizations and those who did not (Robison SG. Pediatrics. 2013;132[1]:44-48).
Subscribe to Contemporary Pediatrics to get monthly clinical advice for today's pediatrician.
CDC recommends nirsevimab be prioritized for highest-risk infants amid limited availability
October 26th 2023The Centers for Disease Control and Prevention is advising providers to prioritize 100 mg doses of nirsevimab, a monoclonal antibody FDA-approved to prevent respiratory syncytial virus (RSV), for infants at the highest risk of severe RSV disease.
Navigating a complex case of pediatric COVID-19 with immunomodulatory therapies
October 21st 2023Eculizumab and anakinra should be considered in critically ill patients with severe infections that require immunomodulating therapies for life-threatening dysregulation, according to a poster session at the 2023 American Academy of Pediatrics National Conference & Exhibition.
